Literature DB >> 9733616

Pulmonary LPS-binding protein (LBP) upregulation following LPS-mediated injury.

R D Klein1, G L Su, A Aminlari, W H Alarcon, S C Wang.   

Abstract

BACKGROUND: The acute respiratory distress syndrome (ARDS) causes significant morbidity and mortality among trauma patients. Although multiple factors have been implicated, pulmonary injury in this population may be due to inflammatory mediators released in response to stimuli such as endotoxin (LPS). LBP plays an integral part in LPS-mediated release of inflammatory cytokines and increased local expression of LBP as the result of a primary injury may prime the lung to secondary LPS-mediated damage.
MATERIALS AND METHODS: To determine the magnitude of pulmonary LBP upregulation following LPS injury we challenged rats with either intravenous (IV) or intratracheal (IT) LPS. Animals from each group were euthanized at 1, 2, 4, and 8 h postchallenge. Lung LBP and CD14 mRNA levels were assayed by Northern blot. Serum and bronchoalveolar lavage (BAL) fluid were assayed for inflammatory cytokines (TNF-alpha, MCP-1, IL-1beta, IL-6, and IL-10) by ELISA.
RESULTS: LBP and CD14 mRNA levels were found to increase significantly in lung tissue after both IV and IT LPS with the IV LPS animals having a greater increase over 8 h. Serum TNF-alpha was significantly elevated in the IV LPS group whereas very low levels were detected in the BAL. Only BAL TNF-alpha was increased in the IT group at 8 h.
CONCLUSION: Local pulmonary LBP and CD14 mRNA are both upregulated after either systemic or local LPS exposure. Such upregulation may render thelung more susceptible to local immune overactivation and injury during subsequent exposures to LPS. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9733616     DOI: 10.1006/jsre.1998.5396

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  4 in total

1.  The Lung-Liver Axis: A Requirement for Maximal Innate Immunity and Hepatoprotection during Pneumonia.

Authors:  Kristie L Hilliard; Eri Allen; Katrina E Traber; Kazuko Yamamoto; Nicole M Stauffer; Gregory A Wasserman; Matthew R Jones; Joseph P Mizgerd; Lee J Quinton
Journal:  Am J Respir Cell Mol Biol       Date:  2015-09       Impact factor: 6.914

2.  Pharmacokinetic-Pharmacodynamic Modeling for Coptisine Challenge of Inflammation in LPS-Stimulated Rats.

Authors:  Yingfan Hu; Li Wang; Li Xiang; Jiasi Wu; Wen'ge Huang; Chensi Xu; Xianli Meng; Ping Wang
Journal:  Sci Rep       Date:  2019-02-05       Impact factor: 4.379

3.  Korean Red Ginseng Saponin Fraction Downregulates Proinflammatory Mediators in LPS Stimulated RAW264.7 Cells and Protects Mice against Endotoxic Shock.

Authors:  Taddessee Yayeh; Kun-Ho Jung; Hye Yoon Jeong; Ji-Hoon Park; Yong-Bum Song; Yi-Seong Kwak; Heun-Soo Kang; Jae Youl Cho; Jae-Wook Oh; Sang-Keun Kim; Man Hee Rhee
Journal:  J Ginseng Res       Date:  2012-07       Impact factor: 6.060

4.  Host responses to concurrent combined injuries in non-human primates.

Authors:  Matthew J Bradley; Diego A Vicente; Benjamin A Bograd; Erin M Sanders; Crystal L Leonhardt; Eric A Elster; Thomas A Davis
Journal:  J Inflamm (Lond)       Date:  2017-11-02       Impact factor: 4.981

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.